1. Home
  2. AGEN vs SMJF Comparison

AGEN vs SMJF Comparison

Compare AGEN & SMJF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Agenus Inc.

AGEN

Agenus Inc.

HOLD

Current Price

$3.95

Market Cap

126.2M

Sector

Health Care

ML Signal

HOLD

SMJF

SMJ International Holdings Inc. Class A Ordinary Shares

N/A

Current Price

$3.03

Market Cap

123.8M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
AGEN
SMJF
Founded
1994
1988
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
126.2M
123.8M
IPO Year
1999
N/A

Fundamental Metrics

Financial Performance
Metric
AGEN
SMJF
Price
$3.95
$3.03
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$14.50
N/A
AVG Volume (30 Days)
393.6K
902.6K
Earning Date
06-22-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
100.00
N/A
EPS
N/A
N/A
Revenue
$42,877,086.00
N/A
Revenue This Year
$5.19
N/A
Revenue Next Year
$68.25
N/A
P/E Ratio
$8.89
$68.08
Revenue Growth
89.95
N/A
52 Week Low
$1.38
$0.82
52 Week High
$7.34
$5.70

Technical Indicators

Market Signals
Indicator
AGEN
SMJF
Relative Strength Index (RSI) 66.67 45.57
Support Level $3.75 $0.82
Resistance Level $4.66 $3.78
Average True Range (ATR) 0.25 0.57
MACD 0.06 0.12
Stochastic Oscillator 87.63 58.91

Price Performance

Historical Comparison
AGEN
SMJF

About AGEN Agenus Inc.

Agenus Inc is an American clinical-stage company with a pipeline of therapies designed to activate the body's immune system to fight cancer and infections, including immune-modulatory antibodies, adoptive cell therapies through its subsidiary MiNK Therapeutics Inc. and vaccine adjuvants through its subsidiary SaponiQx Inc. This robust product pipeline is supported by company's in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. The company's antibody candidates are botensilimab (a proprietary next-generation Fc-engineered CTLA-4 antibody, also known as AGEN1811) and balstilimab (a PD-1 antibody).

About SMJF SMJ International Holdings Inc. Class A Ordinary Shares

SMJ International Holdings Inc specializes in the sale and distribution of a wide range of flooring products such as carpet tiles, broadloom carpets and vinyl tiles. The company operates under the proprietary brand 'SMJ'.The company also supplies environmentally friendly flooring products, promoting sustainable building practices in Asia. It has presence in several countries including Malaysia, Indonesia, Philippines, Hong Kong, PRC, Taiwan, Korea, Thailand, Vietnam, Brunei, and India. It generates revenue mainly through the sale and distribution of its flooring products prominently in Singapore.

Share on Social Networks: